Align Technology Q3 Earnings Call Highlights

Align Technology (ALGN) reported Q3 revenue decline but scanner placements grew by double digits, reaching over 157,000 units. International markets drove volume growth, with double-digit increases in Latin America, EMEA, and APAC. GAAP EPS was $1.90, up from $0.78 YoY. The company expects Q4 revenue of $1.0B-$1.02B and narrowed fiscal 2026 revenue outlook to $4.11B-$4.13B. CEO transition announced with Jennifer Davis set to take over on Dec. 31.

Original reporting
Published Oct 29, 2026, 2:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 2:11 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Align Technology Q3 Earnings Call Highlights — source image
Decision brief

The 30-second read

$ALGNNeutralMed
01

Why it matters

Earnings beat and a $500M buyback plan provide a short‑term catalyst, while modest guidance may temper long‑term expectations.

02

Market read

Align's earnings and guidance impact the dental technology sector and related financing partners, with potential ripple effects on hardware suppliers.

03

What to watch

Potential headwinds from lower clear aligner ASPs and higher transportation costs may pressure margins if not offset by further efficiency gains.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

The article summarizes Align Technology's Q3 earnings call, highlighting financial results, operational metrics, and leadership change.

Company-level read

Ticker impact

$ALGNNeutralHigh confidence
Context

Align Technology reported Q3 GAAP EPS of $1.90, GAAP operating margin of 16.7% and announced a $500M share repurchase plan for FY2026, plus a CEO transition.

Expected impact

likely modest upside as investors price in the buyback and earnings beat, tempered by guidance indicating slower revenue growth

Evidence & confidence

The combination of better-than-expected earnings, a sizable share repurchase, and a clear guidance range provides a concrete catalyst for short-term price movement.

Market effects

Dental and orthodontic device sector may see increased investor interest due to Align's strong scanner placement growth and financing initiatives.

Positive outlook for North American DSO shipments could boost related equipment suppliers in the region.

Align's international volume growth signals broader demand for digital orthodontic solutions worldwide.

Counterpoint

Guidance suggests only low‑single‑digit revenue growth and a 1% price decline, which could limit upside despite the buyback.

Key entities

  • Align Technology

    US‑listed dental device maker (NASDAQ:ALGN).

  • Joseph Hogan

    Outgoing CEO of Align Technology.

  • Jennifer Davis

    CEO‑elect of Align Technology.

Related articles

$ALGNMed

Align Technology Inc (ALGN) Q3 2026 Earnings Call Highlights: Record Doctor Submitters

Align Technology (ALGN) reported Q3 2026 earnings with record 91,000 doctor submitters (+3% YoY) and Clear Aligner shipments up 6.6% to 691,000. Non-GAAP operating margin was 24.4%, exceeding outlook. Revenue growth slowed to 1.9% YoY, with Systems & Services revenue down 7.6%. ASP declined 2.3% YoY. Q4 guidance was reduced due to consumer challenges and lower ASP assumptions. The company highlighted innovation in sports mouthguards and margin improvement plans for 2027.

$ALGNMedAI 8/10

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls

Align Technology (ALGN) reported Q3 2026 earnings of $2.80 per share, up 7.3% YoY, and revenues of $1.01B, up 1.9% YoY. Clear Aligner shipments increased 6.6% YoY. ALGN shares fell 0.7% post-earnings. The company lowered its 2026 revenue outlook, citing softer expectations for Systems and Services business. Q4 revenue guidance is $1.00-$1.02B, below consensus of $1.05B.